Pricing

POINT Biopharma Global Inc (PNT)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Joe McCann
Employees: 70
Web site: pointbiopharma.com
4850 WEST 78TH STREET, INDIANAPOLIS, IN, 46268
(317) 543-9957

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

All 13F Filers Prior Change Hedge Funds 1 Prior Change
POINT Biopharma Global Inc. focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioliand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the. treatment of non-metastatic. castration sensitive prostate cancer, which is under study.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available